The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Latanoprost-Global Market Insights and Sales Trends 2025
Synopsis
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
The global Latanoprost market size is expected to reach US$ 1603.1 million by 2029, growing at a CAGR of 2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Latanoprost in various end use industries. The expanding demands from the Open-angle Glaucoma and Close-angle Glaucoma, are propelling Latanoprost market. Brand Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Generic Drug segment is estimated at % CAGR for the next seven-year period.
Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Latanoprost, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Latanoprost market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Latanoprost market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Latanoprost sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Latanoprost covered in this report include Pfizer, Mylan, Novartis, Apotex, Teva, Taj Pharma and CR Zizhu, etc.
The global Latanoprost market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Global Latanoprost market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Latanoprost market, Segment by Type:
Brand Drug
Generic Drug
Global Latanoprost market, by Application
Open-angle Glaucoma
Close-angle Glaucoma
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Latanoprost manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Latanoprost in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
The global Latanoprost market size is expected to reach US$ 1603.1 million by 2029, growing at a CAGR of 2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Latanoprost in various end use industries. The expanding demands from the Open-angle Glaucoma and Close-angle Glaucoma, are propelling Latanoprost market. Brand Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Generic Drug segment is estimated at % CAGR for the next seven-year period.
Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Latanoprost, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Latanoprost market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Latanoprost market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Latanoprost sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Latanoprost covered in this report include Pfizer, Mylan, Novartis, Apotex, Teva, Taj Pharma and CR Zizhu, etc.
The global Latanoprost market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Global Latanoprost market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Latanoprost market, Segment by Type:
Brand Drug
Generic Drug
Global Latanoprost market, by Application
Open-angle Glaucoma
Close-angle Glaucoma
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Latanoprost manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Latanoprost in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Latanoprost Market Overview
1.1 Latanoprost Product Overview
1.2 Latanoprost Market Segment by Type
1.2.1 Brand Drug
1.2.2 Generic Drug
1.3 Global Latanoprost Market Size by Type
1.3.1 Global Latanoprost Market Size Overview by Type (2018-2029)
1.3.2 Global Latanoprost Historic Market Size Review by Type (2018-2023)
1.3.3 Global Latanoprost Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Latanoprost Sales Breakdown by Type (2018-2023)
1.4.2 Europe Latanoprost Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Latanoprost Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Latanoprost Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Latanoprost Sales Breakdown by Type (2018-2023)
2 Global Latanoprost Market Competition by Company
2.1 Global Top Players by Latanoprost Sales (2018-2023)
2.2 Global Top Players by Latanoprost Revenue (2018-2023)
2.3 Global Top Players by Latanoprost Price (2018-2023)
2.4 Global Top Manufacturers Latanoprost Manufacturing Base Distribution, Sales Area, Product Type
2.5 Latanoprost Market Competitive Situation and Trends
2.5.1 Latanoprost Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Latanoprost Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Latanoprost as of 2022)
2.7 Date of Key Manufacturers Enter into Latanoprost Market
2.8 Key Manufacturers Latanoprost Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Latanoprost Status and Outlook by Region
3.1 Global Latanoprost Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Latanoprost Historic Market Size by Region
3.2.1 Global Latanoprost Sales in Volume by Region (2018-2023)
3.2.2 Global Latanoprost Sales in Value by Region (2018-2023)
3.2.3 Global Latanoprost Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Latanoprost Forecasted Market Size by Region
3.3.1 Global Latanoprost Sales in Volume by Region (2024-2029)
3.3.2 Global Latanoprost Sales in Value by Region (2024-2029)
3.3.3 Global Latanoprost Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Latanoprost by Application
4.1 Latanoprost Market Segment by Application
4.1.1 Open-angle Glaucoma
4.1.2 Close-angle Glaucoma
4.2 Global Latanoprost Market Size by Application
4.2.1 Global Latanoprost Market Size Overview by Application (2018-2029)
4.2.2 Global Latanoprost Historic Market Size Review by Application (2018-2023)
4.2.3 Global Latanoprost Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Latanoprost Sales Breakdown by Application (2018-2023)
4.3.2 Europe Latanoprost Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Latanoprost Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Latanoprost Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Latanoprost Sales Breakdown by Application (2018-2023)
5 North America Latanoprost by Country
5.1 North America Latanoprost Historic Market Size by Country
5.1.1 North America Latanoprost Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Latanoprost Sales in Volume by Country (2018-2023)
5.1.3 North America Latanoprost Sales in Value by Country (2018-2023)
5.2 North America Latanoprost Forecasted Market Size by Country
5.2.1 North America Latanoprost Sales in Volume by Country (2024-2029)
5.2.2 North America Latanoprost Sales in Value by Country (2024-2029)
6 Europe Latanoprost by Country
6.1 Europe Latanoprost Historic Market Size by Country
6.1.1 Europe Latanoprost Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Latanoprost Sales in Volume by Country (2018-2023)
6.1.3 Europe Latanoprost Sales in Value by Country (2018-2023)
6.2 Europe Latanoprost Forecasted Market Size by Country
6.2.1 Europe Latanoprost Sales in Volume by Country (2024-2029)
6.2.2 Europe Latanoprost Sales in Value by Country (2024-2029)
7 Asia-Pacific Latanoprost by Region
7.1 Asia-Pacific Latanoprost Historic Market Size by Region
7.1.1 Asia-Pacific Latanoprost Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Latanoprost Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Latanoprost Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Latanoprost Forecasted Market Size by Region
7.2.1 Asia-Pacific Latanoprost Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Latanoprost Sales in Value by Region (2024-2029)
8 Latin America Latanoprost by Country
8.1 Latin America Latanoprost Historic Market Size by Country
8.1.1 Latin America Latanoprost Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Latanoprost Sales in Volume by Country (2018-2023)
8.1.3 Latin America Latanoprost Sales in Value by Country (2018-2023)
8.2 Latin America Latanoprost Forecasted Market Size by Country
8.2.1 Latin America Latanoprost Sales in Volume by Country (2024-2029)
8.2.2 Latin America Latanoprost Sales in Value by Country (2024-2029)
9 Middle East and Africa Latanoprost by Country
9.1 Middle East and Africa Latanoprost Historic Market Size by Country
9.1.1 Middle East and Africa Latanoprost Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Latanoprost Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Latanoprost Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Latanoprost Forecasted Market Size by Country
9.2.1 Middle East and Africa Latanoprost Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Latanoprost Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Latanoprost Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Latanoprost Products Offered
10.1.5 Pfizer Recent Development
10.2 Mylan
10.2.1 Mylan Company Information
10.2.2 Mylan Introduction and Business Overview
10.2.3 Mylan Latanoprost Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Mylan Latanoprost Products Offered
10.2.5 Mylan Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Latanoprost Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis Latanoprost Products Offered
10.3.5 Novartis Recent Development
10.4 Apotex
10.4.1 Apotex Company Information
10.4.2 Apotex Introduction and Business Overview
10.4.3 Apotex Latanoprost Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Apotex Latanoprost Products Offered
10.4.5 Apotex Recent Development
10.5 Teva
10.5.1 Teva Company Information
10.5.2 Teva Introduction and Business Overview
10.5.3 Teva Latanoprost Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Teva Latanoprost Products Offered
10.5.5 Teva Recent Development
10.6 Taj Pharma
10.6.1 Taj Pharma Company Information
10.6.2 Taj Pharma Introduction and Business Overview
10.6.3 Taj Pharma Latanoprost Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Taj Pharma Latanoprost Products Offered
10.6.5 Taj Pharma Recent Development
10.7 CR Zizhu
10.7.1 CR Zizhu Company Information
10.7.2 CR Zizhu Introduction and Business Overview
10.7.3 CR Zizhu Latanoprost Sales, Revenue and Gross Margin (2018-2023)
10.7.4 CR Zizhu Latanoprost Products Offered
10.7.5 CR Zizhu Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Latanoprost Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Latanoprost Industrial Chain Analysis
11.4 Latanoprost Market Dynamics
11.4.1 Latanoprost Industry Trends
11.4.2 Latanoprost Market Drivers
11.4.3 Latanoprost Market Challenges
11.4.4 Latanoprost Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Latanoprost Distributors
12.3 Latanoprost Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
